Its a paradigm shift in how we treat male metabolic hypogonadism
Anecdotal reports of sleep disturbance are rare and may relate to placebo effect, correction of deficiency, or individual sensitivity
Three flavors: Blueberry Muffin (290 cal), Strawberries & Cream (330 cal), Cookies & Cream (330 cal)
Both are powerful brightening agents, but they target dullness, uneven skin tone, dark spots, and acne marks in distinct ways
The CheckMate 238 (NCT02388906) trial compared nivolumab with ipi10 and found that nivolumab produced superior RFS and had a more tolerable safety profile.[24] Pembrolizumab produced superior RFS compared with placebo, with data on OS still maturing in the MK-3475-054/KEYNOTE-054 trial (NCT02362594).[25] Dabrafenib plus trametinib produced superior RFS compared with placebo, with data on OS still maturing in the COMBI-AD trial (NCT01682083).[26] Single-agent BRAF-inhibitor therapy with vemurafenib did not show improved RFS compared with placebo in the BRIM8 trial (NCT01667419).[27] The benefit of immunotherapy with ipilimumab, nivolumab, and pembrolizumab has been seen regardless of programmed death-ligand 1 (PD-L1) expression or the presence of BRAF pathogenic variants
